Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
-
-
- Triggering Signals of BRCA1 Breast Cancer (K Kessenbrock)
- Testing Diverse Groups Finds New Breast Cancer Genes (L Teras)
- Black Women & Genetic Testing (J Palmer)
- Women 65+ & Genetic Tests for Breast Cancer Risk (L Teras)
- High-Risk Genes and Screening (A Patel)
- New Risk Calculation May Affect Breast Cancer Screening (L Teras)
- Black Men and Breast Cancer (H Sung)
-
- Platelets May Help Breast Cancer Spread (E Battinelli)
- Natural Killer Cells & TNBC (R. Chakrabarti)
- 3D Mini Breast Tumors (K Varley)
- Improving Chemotherapy (O Sahin)
- Combo Treatment for TNBC (K Varley)
- Treatments Attack Cell Division (A Holland)
- ER+ Treatment in Mice (P Kenny)
- Blood DNA Monitors Metastasis Treatment (H P Ji)
- PTK6 Gene as Treatment Target (H Irie)
- Time-Lapse Cell Movies (S Spencer)
-
-
- Better Survival Requires Better Insurance (J Zhao)
- Cancer Disparities in the US (F. Islami)
- Medicaid Eligibility Limits (J Zhao)
- Clinical Trial Treatment Cost App (L Hamel)
- Exercise & Sitting Time (E. Rees-Punia)
- Podcasts, TheoryLab
- Cancer Information about LGBTQ People (B. Charlton)
- Patients Health Insurance Tool (M. Politi)
- Housing Assistance and Mammograms (H Lee)
- Breast Cancer Treatment in Ethiopia (A. Jemal)
- Predicting the Effects of Liver Cancer (C. Wray)
- Disparities' Effect on Cancer Recurrence (M. Hassett)
-
- New Treatment for Neuroblastoma (A Heczey)
- Oncogenic Fusions AML (S Meshinchi)
- Medicare Expansion Improves Survival (X Han)
- Dobbs v Jackson: What to Know (X Han)
- Genetic Risks (L Teras)
- New Medulloblastoma Drugs (J Rodriguez-Blanco)
- Potential New Hope for MLL (J Grembecka)
- Increase in Brain Tumor Diagnosis (K Miller)
- Longer Life Expectancy for Survivors (J Yeh)
- Potential Target for New Osteosarcoma Drugs (C Benavente)
- At-Home Chemo for Children with HR ALL (L Ranney)
- Childhood Cancer Research Landscape Report
-
-
- Tumor-Infiltrating Neutrophils (R. Sumagin)
- New Epigenetic Target (K Rai)
- Extra Chromosomes (Aneuploidy) Effect on Cancer (J. Sheltzer)
- Discovery of a New Biomarker Is the First Step to New Treatment (C. Maher)
- Designer Virus Targets and Kills CRC Cells in Mice (S. Warner)
- Tiny Sensor in Mice May Find Cancer That's Trying to Spread (L. Hao)
- Targeting a Protein “Turned on” by Mistake (N. Gao)
- Spatial Map Intestines (J Hickey)
- CRC Treatment Podcasts
-
- Keto Molecule & Colorectal Cancer (M Levy)
- Availability of Healthy Food (L Tussing-Humphreys)
- 45 Min/Day of Physical Activity (A Minihan)
- Fewer than 10K Steps/Day (A Patel)
- Yogurt & Cheese & ER- Breast Cancer (M McCullough)
- Stage 2 Clinical Trials for New Endometrial Cancer Drug (V Bae-Jump)
- Hard-to-Starve Pancreatic Cancer Cells (N Kalaany)
- Coffee Risks for Colorectal Cancer (C Um)
- Food Parasite & Brain Cancer Risk (J Hodge)
- Exercise & Quality of Life in Older Survivors (E Rees-Punia)
- 21 Metabolites Linked with Breast Cancer (Y Wang)
- Replacing Sitting May Affect Weight (E Rees-Punia)
- CPS-3 Researchers Ask What People Eat and Check Urine Samples (Y Wang)
- Video Games Motivate Exercise? (E. Lyons)
- Food Choices and Colon Cancer Risk (P. Chandler)
- Race, Exercise & Breast Cancer (C. Dallal)
- Diet with Colorectal Cancer (M. Guinter)
-
- Biomarkers May Improve Prediction (Y Wang)
- Kickstart NSCLCs Clinical Trials (L. Eichner)
- Mapping Mitochondria's “Dance” (D. Shackleford)
- E-Cig Use Ages 18 to 29 (P. Bandi)
- Stopping Smoking Earlier in Life (F Islami)
- Most with Lung Cancer Smoked (A Jemal)
- Furthering Lung Cancer Screening & Equity (S Fedewa)
- Mouse Lung Organoids for Research (C Kim)
- Quality of Life for Lung Cancer Survivors (J Temel)
- Precision Therapies for NSCLC (P Jänne)
- Cancer Deaths from Smoking (F Islami)
- Lung Cancer Surgery Disparities (A Jemal)
- BRG1-Deficient Lung Cancers (C Kim)
- Yoga for Couples with Lung Cancer (K Milbury)
- Metabolic Differences as New Drug Targets (A Marcus)
-
- CPS-II & CPS-3 Inform About Risks of Ovarian Cancer
- Machine Learning & Glowing Nanosensors (D Heller)
- Ovarian Cancer May Start in Fallopian Tube Cells (K Lawrenson)
- New Gene Linked with Deadliest Type (C Han)
- Gene-Testing Tools May Personalize Care (A Sood)
- Chromosome-Hoarding Ovarian Cancer Cells & Treatment (J Sheltzer)
- Nanoparticles as Drug Delivery for Metastases (X Lu)
- Turning Off 2 Proteins to Slow HGSC (P Kreeger)
- Targeted Light Therapy in Mice (M Bai)
- Nanoparticles, CAR T, and CRISPR (M Stephan)
- Endometriosis & Ovarian Cancer in Mice (M Wilson)
- Ovarian Cancer Special Section
-
- 2 New Drug Pathways to EZH2 (Q Cao)
- Proton Beam Therapy (L Nogueira)
- Survivors Who Eat More Chicken and Less Meat (Y Wang)
- Men Who Have Obesity or Who Gain 10+ Pounds After Diagnosis (Y Wang)
- Prostatectomy for Black Men Who Also Have Obesity (A Vidal)
- Medicaid Alone Doesn't Improve Prostate Cancer Care (C Filson)
- 5 Years After Recommending Against Routine PSA Tests (A Jemal)
- Toxicity of Certain Immune Cells in Bone May Present New Treatment (L Cook)
- Heart Medicines May Spur Future Prostate Treatments (I Schlaepfer)
- Genetic Tool for Prostate Cancer in Blacks (K Yamoah)
- New Test May Predict Treatment for Prostate Cancer (R Blind)
- Untreatable Prostate Cancers (W Li)
-
- UV Exposure, Melanoma, & Dark Skin Types (A. Adamson)
- Melanoma and Lipid Droplets (R. White)
- Zebrafish and Acral Melanoma (R. White)
- T-Cell Lymphoma and PD1 (J. Choi)
- New Drug Destroys Cancer-Causing Protein (C. Crews)
- Virus & Merkel Cell Skin Cancer (R. Wang)
- Non-Genetic Drug Resistance (S. Spencer)
- Hijacking the Body's Sugar (R. Wang)
- Telling about High Risk (P. Kanetsky)
- Brain Metastasis and Alzheimer’s (E. Hernando)
- Exhausted Melanoma "Killer" Cells (W. Cui)
5 Things to Know About Dobbs v Jackson & Teens with Cancer
Researchers' data shows the public & state legislators how reproductive laws may affect access to fertility care for adolescents & young adults with cancer.
1. Who’s Affected
Fertility refers to having the ability to conceive a biological child. Both young women and young men with certain types of cancer or who are getting treatment for cancer may have fertility problems. Fertility preservation treatment helps these young people be able to have a biological child later in life.
A recent research study found that more than 2 out of 3 adolescents and young adults who are newly diagnosed with cancer would require fertility preservation treatment.
Adolescents and young adults may want to talk with their doctors about getting treatment to preserve fertility when they've been newly diagnosed with a type of cancer that requires treatment with chemotherapy, radiotherapy, or other treatments that can damage the sexual organs (called gonadotoxic treatment).
Young people may also talk about preserving fertility when their diagnosis isn’t new, but a new treatment plan adds one of those treatments. People who may need such systemic treatments include those with any of these cancers:
- Leukemia
- Lymphoma
- Bone, joint, or soft tissue sarcoma
- Breast cancer in females
- Cervical cancer
- Ovarian cancer
- Uterine cancer
- Testicular cancer
- Other cancers at a regional or distant stage
That means fertility preservation care is essential for more than 2 out of 3 adolescents and young adults who are newly diagnosed with cancer.
2. What’s Happened
The United States Supreme Court’s decision on Dobbs v Jackson reversed Roe v Wade and returned decisions about abortion services to each US state. In many states, abortion restrictions could limit fertility care. That leaves about 1 out of 4 adolescents or young adults with cancer who need fertility preservation living in a state where they may not be able to receive it. Fertility preservation treatment directly affects the ability to conceive a child after cancer treatment is completed.
Our hope is that our state-level data about access to reproductive care will prompt US decision-makers to make laws that ensure young people with cancer are able to access recommended cancer care and fertility preservation care.”
Xuesong Han, PhD
Scientific Director, Health Services Research
American Cancer Society
3. What Populations Are Most at Risk
In a recent study, among adolescents and young adults newly diagnosed with cancer who live in a state where fertility preservation treatment is at risk, 84% lived in high-poverty counties and 65% were girls or women. Texas, Ohio, and Georgia had the most young people with cancer at risk of not being able to get treatment to preserve fertility.
4. What’s at Risk
The court’s decision potentially interferes with fertility preservation that involves genetic testing, as well as the collection of eggs and sperm, and the creation, storage, and disposal of embryos, including those created in vitro.
5. Why We Studied the Need for Fertility Preservation in Adolescents and Young Adults with Cancer
“We took on this study because the public and our state legislators need accurate information to be able to understand the potential consequences of reproductive legislation on access to fertility care for young people with cancer,” Xuesong Han, PhD, says. She co-wrote a study published in The Lancet Oncology with her American Cancer Society (ACS) Surveillance and Health Equity research colleague, Robin Yabroff, PhD, along with two other researchers.
Ongoing monitoring of the health effects of the US Supreme Court’s decision and states’ decisions is warranted, the authors say.
“Our hope is that our state-level data about access to reproductive care will prompt US decision-makers to make laws that ensure young people with cancer are able to access recommended cancer care and fertility preservation care,” Han adds.